Myoclonic seizures in a preterm baby: Is this a presentation of venlafaxine withdrawal?

Singapore Medical Journal

Volumn 55, Issue 4, 2014, Pages

  Ansary, Althaf ^a   Ibhanesebhor, Samuel ^b   Manjunatha, Chikkanayakanahalli ^b  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b WISHAW GENERAL HOSPITAL   (United Kingdom)

Author keywords

Amplitude integrated electroencephalography; Myoclonic seizures; Neonatal abstinence syndrome; Preterm neonate; Venlafaxine

Indexed keywords

PHENOBARBITAL; PHENYTOIN; SURFACTANT; VENLAFAXINE; ANTIDEPRESSANT AGENT; CYCLOHEXANOL DERIVATIVE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AMPLITUDE INTEGRATED ELECTROENCEPHALOGRAPHY; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DEPRESSION; DRUG WITHDRAWAL; ECHOGRAPHY; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; INBORN ERROR OF METABOLISM; INFANTILE SPASM; LOADING DRUG DOSE; LUNG VENTILATION; MYOCLONUS SEIZURE; NEUROLOGIC EXAMINATION; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; TENDON REFLEX; ADVERSE EFFECTS; CHEMICALLY INDUCED; ENVIRONMENTAL EXPOSURE; PREGNANCY; SEIZURE;

ANTIDEPRESSIVE AGENTS; CYCLOHEXANOLS; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MAGNETIC RESONANCE IMAGING; MATERNAL EXPOSURE; PHENOBARBITAL; PHENYTOIN; PREGNANCY; SEIZURES; SEROTONIN UPTAKE INHIBITORS;

EID: 84898853540     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: 10.11622/smedj.2014061     Document Type: Article

References (16)

1. Patil AS, Kuller JA, Rhee EH. Antidepressants in pregnancy: a review of commonly prescribed medications. Obstet Gynecol Surv 2011; 66:777-87.
2. Brown CS. Depression and anxiety disorders. Obstet Gynecol Clin North Am 2001; 28:241-68.
3. Hostetter A, Ritchie JC, Stowe ZN. Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women. Biol Psychiatry 2000; 48:1032-4.
4. Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006; 160:173-6.
5. Oberlander TF, Misri S, Fitzgerald CE, et al. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65:230-7.
6. Klinger G, Merlob P. Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. Isr J Psychiatry Relat Sci 2008; 45:107-13.
7. Einarson A, Fatoye B, Sarkar M, et al. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry 2001; 158:1728-30.
8. De Moor RA, Mourad L, ter Haar J, Egberts AC. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy]. Ned Tijdschr Geneeskd 2003; 147:1370-2. Dutch.
9. Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005; 365:482-7.
10. Pakalapati RK, Bolisetty S, Austin MP, Oei J. Neonatal seizures from in utero venlafaxine exposure. Paediatr Child Health 2006; 42:737-8.
11. Hoppenbrouwers CJ, Bosma J, Wennink HJ, et al. Neonatal seizures on EEG after in utero exposure to venlafaxine. Br J Clin Pharmacol 2010; 70:454-6.
12. Sankar MJ, Agarwal R, Aggarwal R, Deorari AK, Paul VK. Seizures in the newborn. Indian J Pediatr 2008; 75:149-55.
13. Volpes JJ. Neonatal Seizures. In: Neurology of the newborn. 5th ed. Philadelphia: Saunders Elsevier; 2008, p223-30.
14. Thornberg E, Thiringer K. Normal patterns of cerebral function monitor traces in term and preterm neonates. Acta Paediatr Scand 1990; 79:20-5.
15. Olischar M, Klebermass K, Kuhle S, et al. Reference values for amplitudeintegrated electroencephalographic activity in preterm infants younger than 30 weeks' gestational age. Pediatrics 2004; 113:e61-6.
16. de Vries LS, Hellström-Westas L. Role of cerebral function monitoring in the newborn. Arch Dis Child Fetal Neonatal Ed 2005; 90:F201-7.